AbSci

One of AbSci's standout offerings is SoluPure, a chromatography-free purification method that simplifies the downstream processing of proteins. This method removes bottlenecks typically associated with traditional purification techniques, making the production process faster and more cost-effective. AbSci's high-throughput workflow can generate cell lines that produce folded, active protein products in as little as three months, significantly reducing the time and resources needed for drug development.

AbSci's business model is built around providing cutting-edge biomanufacturing solutions that introduce efficiencies and cost savings to the biotech industry. The company makes money by partnering with pharmaceutical and biotech companies, offering them proprietary technologies and services that enhance their drug discovery and manufacturing processes. By doing so, AbSci aims to replace traditional mammalian expression platforms, such as CHO cells, with its more efficient and scalable solutions.

The company is supported by a group of experienced investors and is driven by a team of passionate, imaginative, and accomplished scientists. These professionals are dedicated to challenging established industry practices and creating extraordinary tools for drug discovery and manufacturing.

In summary, AbSci is a disruptive force in the biotech industry, offering innovative solutions that streamline protein production and purification, ultimately transforming how life-changing biologics are made.